Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

R A Larson; M Boogaerts; E Estey; C Karanes; E A Stadtmauer; E L Sievers; P Mineur; J M Bennett; M S Berger; C B Eten

doi:10.1038/sj.leu.2402677

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

Identifier:nobleid.org/w1/20260515/CDB7A7F3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CDB7A7F3.svg?ark=w1%2F20260515%2FCDB7A7F3)](https://nobleid.org/work/w1/20260515/CDB7A7F3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

Identifier:nobleid.org/w1/20260515/CDB7A7F3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CDB7A7F3.svg?ark=w1%2F20260515%2FCDB7A7F3)](https://nobleid.org/work/w1/20260515/CDB7A7F3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work